CompaniesHong KongNews brief

Dizal Pharma Resubmits H-Share Listing Application to Hong Kong Exchange

Published: 28 August 2026 at 08:05Updated: 28 August 2026 at 08:29By 24TopNews Editorial Desk

On August 27, Dizal Pharmaceutical resubmitted its application to the Hong Kong Stock Exchange for the issuance of H-shares and listing on the main board. The company also published the relevant application materials on the exchange's website on the same day.